4,542
Views
2
CrossRef citations to date
0
Altmetric
Original research

Glycosylated hemoglobin as a predictor of mortality in severe pneumonia by COVID-19

, , , , , , , , , , & ORCID Icon show all
Pages 1077-1082 | Received 21 Jan 2021, Accepted 04 May 2021, Published online: 17 May 2021

References

  • Singh AK, Gupta R, Ghosh A, et al. Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):303–310. DOI: 10.1016/j.dsx.2020.04.004.
  • Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 March 13;180(7):934. Published online.
  • Vaduganathan M, Vardeny O, Michel T, et al. Renin angiotensin aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020 March;30: DOI:10.1056/NEJMsr2005760.
  • Chen X, Hu W, Ling J, et al. Hypertension and diabetes delay the viral clearance in COVID-19 patients. medRxiv. 2020;2020:2003.2022.20040774.
  • Rao S, Lau A, So H-C. Exploring diseases/traits and blood proteins causally related to 284 expression of ACE2, the putative receptor of 2019-nCov: a Mendelian randomization analysis. medRxiv. 2020;43(7):1416–1426. DOI: 10.2337/dc20-0643.
  • Fernandez C, Rysa J, Almgren P, et al. Plasma levels of the proprotein convertase furin and incidence of diabetes and mortality. J Intern Med. 2018;284(4):377e87.
  • Kulcsar KA, Coleman CM, Beck SE, et al. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. JCI Insight. 2019;4(20):131774.
  • Maddaloni E, Buzzetti R. Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics. Diabetes Metab Res Rev. 2020 Mar 31; e33213321. doi:10.1002/dmrr.3321.
  • Zuurbier CJ, Demirci C, Koeman A, et al. Short term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. J Appl Physiol. 2005;99(4):1471–1476.
  • Avogaro A, Albiero M, Menegazzo L, et al. Disfuncion endothelial en la diabetes. Diabetes Care. 2013;13(5):3–8.
  • Giacco F, Brownlee M, Schmidt AM. Oxidative stress and diabeticcomplications. Circ Res. 2010;107(9):1058–70.5.
  • Luethi N, Cioccari L, Tanaka A, et al. Glycated hemoglobin A1c levels are not affected by critical illness. Crit Care Med. 2016;44(9):1692–1694.
  • Akbar DH. Bacterial pneumonia: comparison between diabetics and non-diabetics. Acta Diabetol. 2001;38(2):77e82.
  • Hyperglycemia CA. COVID-19: what was known and what is really new? Diabetes Res Clin Pract. 2020;167:108383.
  • Glycemic targets: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S55–s64.
  • Dogné S, Flamion B, Caron N. Endothelial glycocalyx as a shield against diabetic vascular complications: involvement of hyaluronan and hyaluronidases. Arterioscler Thromb Vasc Biol. 2018;38(7):1427–1439.
  • Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020 May 2;395(10234):1417–1418.
  • Lee YS, Min KH, Lee SY, et al. The value of glycated hemoglobin as predictor of organ dysfunction in patients with sepsis. PLoS One. 2019 2019 May 6;14(5):e0216397. Published.
  • Su YW, Hsu CY, Guo YW, et al. Usefulness of the plasma glucose concentration-to-HbA 1c ratio in predicting clinical outcomes during acute illness with extreme hyperglycaemia. Diabetes Metab. 2017;43(1):40–47.
  • Klein SJ, Fries D, Kaser S, et al. Unrecognized diabetes in critically ill COVID-19 patients. Crit Care. 2020;24(406). DOI:10.1186/s13054-020-03139-3.
  • Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020;164:108214.
  • Merzon E, Green I, Shpigelman M, et al. Eldor. Haemoglobin A1c is a predictor of COVID-19 severity in patients with diabetes. Diabetes Metab Res Rev. 2020;e3398. DOI:10.1002/dmrr.3398.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.